Skip to content
New to DAT Supply? Create a client account to view pricing, order samples and start your first order.
DAT Supply Log in
Navigation
Profile

Preferences

Choose your market — it sets your site and language.

Start order

Already a member? Log in

How to combine ingredients in a private-label formula

How to combine ingredients in a private-label formula

When developing a private-label supplement, combining ingredients into a single formula requires careful planning to ensure compatibility, stability, and market appeal. This section walks brand owners through the key steps—from selecting active ingredients and choosing the right format to understanding how DAT Supply's Make it Yours programme enables tailored formulations. The focus is on practical considerations such as ingredient interactions, dosage forms, and regulatory compliance, helping you build a product that aligns with your brand vision while leaving final claims and label review in your hands.

What this active is and typical formats

An 'active' refers to the key ingredient or blend that delivers the intended benefit of the supplement. Typical formats include capsules (hard or softgel), tablets, powders, liquids, and gummies. Each format has specific requirements for ingredient compatibility—for example, powders may require flow agents, while liquids need emulsifiers. Understanding the active's physical and chemical properties helps determine which format best preserves stability and bioavailability.

Category fit for brand ranges

Combining ingredients often targets a specific category such as energy, immunity, joint support, or sleep. When planning a brand range, consider how the active fits alongside existing or planned products. For instance, a multivitamin with added botanicals may complement a line of single-ingredient supplements. Ensure the combined formula addresses a clear consumer need without overlapping or conflicting with other products in your range.

Formulation and formulation considerations

Key considerations include ingredient compatibility (e.g., no negative interactions), dosage accuracy, and stability over shelf life. Excipients like binders, fillers, and coatings may be needed to ensure uniformity and ease of manufacturing. The chosen format influences these factors—for example, tablets require compression-friendly blends, while capsules can accommodate powders or liquids. Always work with your manufacturer to test stability and potency before scaling.

Compliance and label responsibility

While DAT Supply follows Good Manufacturing Practices (GMP), the brand owner is ultimately responsible for ensuring the final product complies with all applicable regulations in their target market. This includes verifying that the combined ingredients are permitted, that label claims are substantiated, and that any required disclaimers are included. DAT Supply does not provide legal or regulatory advice; brand owners should consult qualified professionals for market-specific compliance.

How to brief this active to DAT Supply

To brief an active combination, provide the target dosage per serving, desired format, and any specific ingredient ratios or exclusions. Use the Make it Yours process to select from existing base formulations or request a custom blend. Submit your brief through the online portal or contact your account manager. Include any reference products or competitor benchmarks. DAT Supply will review feasibility, suggest format options, and provide a timeline for samples.

Continue exploring

Where to next?

Browse the reviewed catalogue, request samples, or start an order when you're ready — the DAT Supply portal routes your brief through the right review step.

Quick context request

Get manufacturing context

Drop your work email and a member of the DAT team will follow up with the right context for this concept. Order documents, certificates and pricing are released through the client workspace in the DAT portal.

You will receive a short confirmation email. Order documents (specification, batch-specific COA, packaging documents) are released through the client workspace in the DAT portal once a brief is in place.

/usr/bin/bash: line 5: /tmp/hermes-snap-51302552d562.sh: No such file or directory /usr/bin/bash: line 6: /tmp/hermes-cwd-51302552d562.txt: No such file or directory